BR112021017140A2 - Composições tópicas estáveis de fenoldopam - Google Patents
Composições tópicas estáveis de fenoldopamInfo
- Publication number
- BR112021017140A2 BR112021017140A2 BR112021017140A BR112021017140A BR112021017140A2 BR 112021017140 A2 BR112021017140 A2 BR 112021017140A2 BR 112021017140 A BR112021017140 A BR 112021017140A BR 112021017140 A BR112021017140 A BR 112021017140A BR 112021017140 A2 BR112021017140 A2 BR 112021017140A2
- Authority
- BR
- Brazil
- Prior art keywords
- fenoldopam
- compositions
- composition
- stable topical
- stable
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- TVURRHSHRRELCG-UHFFFAOYSA-N fenoldopam Chemical compound C1=CC(O)=CC=C1C1C2=CC(O)=C(O)C(Cl)=C2CCNC1 TVURRHSHRRELCG-UHFFFAOYSA-N 0.000 title abstract 5
- 229960002724 fenoldopam Drugs 0.000 title abstract 5
- 230000000699 topical effect Effects 0.000 title abstract 4
- 239000003349 gelling agent Substances 0.000 abstract 2
- 229920002401 polyacrylamide Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815893P | 2019-03-08 | 2019-03-08 | |
| PCT/IB2020/051967 WO2020183322A1 (en) | 2019-03-08 | 2020-03-06 | Stable topical compositions of fenoldopam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021017140A2 true BR112021017140A2 (pt) | 2021-11-09 |
Family
ID=69846519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021017140A BR112021017140A2 (pt) | 2019-03-08 | 2020-03-06 | Composições tópicas estáveis de fenoldopam |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11446237B2 (https=) |
| EP (2) | EP3908255B1 (https=) |
| JP (2) | JP7124234B2 (https=) |
| CN (2) | CN116966129A (https=) |
| AU (2) | AU2020236525B2 (https=) |
| BR (1) | BR112021017140A2 (https=) |
| CA (1) | CA3131049A1 (https=) |
| ES (1) | ES2941241T3 (https=) |
| IL (1) | IL286197A (https=) |
| NZ (1) | NZ781774A (https=) |
| WO (1) | WO2020183322A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023257375A1 (en) | 2022-04-21 | 2024-11-07 | Glaukos Corporation | Ophthalmic topical cream compositions |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| ATE210975T1 (de) | 1994-06-23 | 2002-01-15 | Procter & Gamble | Topisch anzuwendende zubereitungen enthaltend n- acetyl-l-cystein |
| US6054429A (en) | 1996-03-08 | 2000-04-25 | Elan Pharmaceuticals, Inc. | Epidural method of producing analgesia |
| AU3869399A (en) | 1998-04-27 | 1999-11-16 | Elan Pharmaceuticals, Inc. | Transdermal administration of fenoldopam |
| JPH11335236A (ja) | 1998-05-22 | 1999-12-07 | Shiseido Co Ltd | 皮膚外用剤 |
| EP1100476B1 (en) * | 1998-07-24 | 2004-06-16 | ALZA Corporation | Formulations for the transdermal administration of fenoldopam |
| US6699497B1 (en) | 1998-07-24 | 2004-03-02 | Alza Corporation | Formulations for the transdermal administration of fenoldopam |
| US7442369B1 (en) * | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
| US7358236B1 (en) | 2002-06-21 | 2008-04-15 | Oxigene, Inc. | Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| WO2005079851A2 (en) | 2004-02-18 | 2005-09-01 | Sepracor, Inc. | Dopamine-agonist combination therapy with sedatives for improving sleep quality |
| WO2005108387A2 (en) | 2004-05-03 | 2005-11-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cytokine inhibitors |
| CN101151028A (zh) * | 2005-03-03 | 2008-03-26 | Isw集团公司 | 局部用凝胶组合物 |
| AU2006265002B2 (en) | 2005-06-30 | 2012-09-20 | Centocor, Inc. | Anti-IL-23 antibodies, compositions, methods and uses |
| JP2009502206A (ja) | 2005-08-03 | 2009-01-29 | ミニュー・セラピューティクス・リミテッド | 腫瘍壊死因子アルファ（ＴＮＦ−α）合成および分泌を調節するための、Ｔ細胞におけるＫｖ１．１電位依存性カリウムチャンネルのモデュレーション、およびＴＮＦ−αの有害な高または低レベルを介しての人の疾患または傷害の治療 |
| WO2009052491A2 (en) | 2007-10-18 | 2009-04-23 | Geraghty, Erin | Fenoldopam formulations and prodrug derivatives |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| WO2009076553A1 (en) | 2007-12-11 | 2009-06-18 | Monroe Stephen H | Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same |
| CA2732439A1 (en) | 2008-07-31 | 2010-02-04 | Case Western Reserve University | Halogen-stabilized insulin |
| JP2011144143A (ja) | 2010-01-15 | 2011-07-28 | Shiseido Co Ltd | 皮膚外用剤 |
| RU2571277C2 (ru) | 2010-10-21 | 2015-12-20 | Галдерма С.А. | Композиции геля с бримонидином и способы применения |
| HUE034480T2 (en) | 2011-04-28 | 2018-02-28 | Platform Brightworks Two Ltd | Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same |
| FR2991177B1 (fr) | 2012-06-01 | 2014-12-19 | Galderma Res & Dev | Compositions topiques, contenant un retinoide, de type emulsion huile dans eau sans emulsionnant |
| AU2014227996B2 (en) * | 2013-03-15 | 2018-08-23 | Vapogenix, Inc. | Novel analgesic compositions |
| JP6893075B2 (ja) | 2014-08-04 | 2021-06-23 | 日東電工株式会社 | 液性免疫誘導促進用組成物及びワクチン医薬組成物 |
| UA121985C2 (uk) * | 2015-01-23 | 2020-08-25 | Др. Редді'З Лабораторіз Лімітед | Нефарбуюча гелева композиція для місцевого застосування, яка містить німесулід |
| EP3506906A4 (en) * | 2016-08-31 | 2020-08-12 | Taro Pharmaceutical Industries Ltd. | TOPICAL FORMULATIONS OF FENOLDOPAM FOR THE TREATMENT OF SKIN DISORDERS |
| MX2020004187A (es) * | 2017-10-24 | 2020-09-21 | Glenmark Pharmaceuticals Ltd | Composicion farmaceutica topica de adapaleno y minociclina. |
-
2020
- 2020-03-06 NZ NZ781774A patent/NZ781774A/en not_active IP Right Cessation
- 2020-03-06 US US17/430,264 patent/US11446237B2/en active Active
- 2020-03-06 EP EP20712690.5A patent/EP3908255B1/en active Active
- 2020-03-06 ES ES20712690T patent/ES2941241T3/es active Active
- 2020-03-06 CN CN202310774370.XA patent/CN116966129A/zh active Pending
- 2020-03-06 CA CA3131049A patent/CA3131049A1/en active Pending
- 2020-03-06 AU AU2020236525A patent/AU2020236525B2/en not_active Ceased
- 2020-03-06 JP JP2021553117A patent/JP7124234B2/ja active Active
- 2020-03-06 WO PCT/IB2020/051967 patent/WO2020183322A1/en not_active Ceased
- 2020-03-06 EP EP23150539.7A patent/EP4218719A3/en not_active Withdrawn
- 2020-03-06 BR BR112021017140A patent/BR112021017140A2/pt active Search and Examination
- 2020-03-06 CN CN202080019392.XA patent/CN113543773B/zh not_active Expired - Fee Related
-
2021
- 2021-09-06 IL IL286197A patent/IL286197A/en unknown
-
2022
- 2022-05-03 AU AU2022202941A patent/AU2022202941A1/en not_active Abandoned
- 2022-08-09 US US17/883,687 patent/US20230059107A1/en not_active Abandoned
- 2022-08-10 JP JP2022127610A patent/JP2022160648A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4218719A2 (en) | 2023-08-02 |
| EP3908255B1 (en) | 2023-01-11 |
| WO2020183322A1 (en) | 2020-09-17 |
| ES2941241T3 (es) | 2023-05-19 |
| JP2022160648A (ja) | 2022-10-19 |
| CN113543773B (zh) | 2023-07-14 |
| EP3908255A1 (en) | 2021-11-17 |
| US20230059107A1 (en) | 2023-02-23 |
| AU2022202941A1 (en) | 2022-05-26 |
| EP4218719A3 (en) | 2023-09-20 |
| US11446237B2 (en) | 2022-09-20 |
| CN116966129A (zh) | 2023-10-31 |
| JP2022515569A (ja) | 2022-02-18 |
| AU2020236525B2 (en) | 2022-02-03 |
| CA3131049A1 (en) | 2020-09-17 |
| IL286197A (en) | 2021-10-31 |
| NZ781774A (en) | 2023-03-31 |
| CN113543773A (zh) | 2021-10-22 |
| AU2020236525A1 (en) | 2021-11-04 |
| JP7124234B2 (ja) | 2022-08-23 |
| US20220040089A1 (en) | 2022-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022010894A2 (pt) | Composições orais úmidas | |
| BR112022004514A2 (pt) | Produto oral com uma amina básica e um agente de pareamento iônico | |
| BR112018011859A2 (pt) | uso de composições tendo um conteúdo de 3,3´-metilenobis(2-metiloxazolidina) na remoção de compostos de enxofre a partir de correntes de processo | |
| BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
| AR098830A2 (es) | Suspensiones acuosas estabilizadas para administración parenteral | |
| PE20080374A1 (es) | Composiciones farmaceuticas de ropinirol | |
| BRPI0500704A (pt) | composições de tratamento pessoal reidratáveis | |
| BR0313723A (pt) | Derivados de benzotiazol tendo atividade de agonista beta-2-adrenorreceptor | |
| BR112018004642A2 (pt) | processo para tratamento capilar | |
| DK1471887T3 (da) | Nanopartikelkompositioner der har lysozym som overfladestabiliseringsmiddel | |
| MX2020005942A (es) | Delgada pelicula oral con alta carga de agente activo. | |
| BR112020019875A8 (pt) | composições tópicas para alívio da dor | |
| BR9907309A (pt) | FluorelastÈmeros curáveis, seu uso e processo para a obtenção dos mesmos | |
| BR112015022765A2 (pt) | composição biocida e processo de tratamento da água ou de superfícies em contato com água | |
| SA522431498B1 (ar) | مشتقات 3، 6-داي أمينو-بيريدازين-3-يل، تركيبات صيدلية تحتوي عليها واستخدامها في صورة عوامل مساعدة على تلاشي الخلايا | |
| UY38068A (es) | Péptidos de la cadena b de la relaxina lipidados modificados y su uso terapéutico | |
| BR112021017612A2 (pt) | Película geradora de aerossol | |
| PE20211113A1 (es) | Agentes de liberacion de gas antimicrobianos y sistemas y metodos para utilizarlos | |
| UY38055A (es) | Composiciones oftálmicas de compuestos de bencimidazol para uso unico diario | |
| BR112021017140A2 (pt) | Composições tópicas estáveis de fenoldopam | |
| BR112023017126A2 (pt) | Uso do composto ativado por akr1c3 | |
| BR112023023129A2 (pt) | Composições orais e métodos relacionados para reduzir a irritação da garganta | |
| AR123251A1 (es) | Una composición insecticida estable en almacenamiento | |
| BRPI0519605A2 (pt) | composiÇÕes de cuidado pessoal | |
| EA202192541A1 (ru) | Фармацевтическая композиция для местного применения в виде водного геля, содержащая, по меньшей мере, амитриптилин |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |